Trial Profile
Pharmacokinetics of ESBA 105 in patients undergoing cataract surgery or combined cataract surgery and vitrectomy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Oct 2013
Price :
$35
*
At a glance
- Drugs ESBA-105 (Primary)
- Indications Ocular inflammation
- Focus Pharmacokinetics
- 24 Oct 2013 New trial record